More than 34 million people in the United States currently have diabetes, and another 86 million pre-diabetics are on the cusp of developing the disease. New investigations into the safety of the heavily prescribed medication uncovered a long list of Invokana side effects.
Type 2 Diabetes
Ketoacidosis, bone fractures, kidney injuries, cardiac complications, UTI and yeast infections, & amputation
Get our reporting in your inbox
Read more about Invokana
FDA Warns Patients to Stop Taking SGLT-2...
James Parker · April 3, 2020
The FDA released a warning about continuing the use of sodium-glucose co-transporter-2 inhibitors before surgery, informing patients that the class of diabetes medications could contribute to a higher risk of ketoacidosis.FDA Regulation
FDA Warns of Rare Genital Gangrene Linke...
James Parker · September 17, 2018
People with diabetes taking Invokana and other SGLT2 inhibitors may be at risk for Fournier's gangrene, a flesh-eating bacterial infection affecting the groin and genitals. SGLT2 inhibitors that may potentially cause Fournier's gangrene include Invokana, Farxiga and Jardiance.FDA Regulation
How to Support People With Diabetes
Ashley Lombardo · November 20, 2017
Do you know someone with diabetes? Check out our tips on how to provide solid diabetes support to friends and family.Health Features
What You Need to Know About Diabetes Drug Side Effects
Ashley Lombardo · November 8, 2017
MedTruth's National Diabetes Month focus is educating patients on how to handle diabetes drug side effects.Health Features
Why Does Invokana Cause Amputations?
Ashley Lombardo · September 8, 2017
While this diabetes drug is known to help lower blood sugar, many hopeful patients are also wondering why does Invokana cause amputations.Health Features
Judge Consolidates Invokana Lawsuits In New Jersey
Ashley Lombardo · February 13, 2017
On Dec. 7, 2016, the U.S. Judicial Panel on Multidistrict Litigation ordered the cases be joined into a multidistrict legislation (MDL). More than 50 Invokana lawsuits related to the controversial diabetes drug have been consolidated in a U.S. District Court of New Jersey.Legal Developments
FDA Strengthens Kidney Warnings On Diabetes Drugs
Ashley Lombardo · July 24, 2016
The Food and Drug Administration (FDA) has updated warnings on four diabetes medications to minimize the risk of acute kidney injury. Used to treat type II diabetes, canagliflozin and dapagliflozin are sodium-glucose cotransporter-2 (SGLT2) inhibitors that work with the kidneys to maintain safe blood sugar levels.FDA Regulation